Wolbachia-Based biocontrol of Aedes aegypti: Current Progress, Challenges, and future prospects

Wolbachia is used as potential bio-control tool to reduce the dengue mosquitoes and also to reduce dengue virus (DENV) load in transinfected Aedes aegypti. Different field trials including the ones by the World Mosquito Program (WMP) have deployed Wolbachia carrying DENV primary vectors at different target sites worldwide. Field trials suggest that through the Population Replacement Strategy (PRS) and Incompatible Insect Technique (IIT), Wolbachia can introgress into the local Ae. aegypti population or reduce the population size of the Aedes aegypti by cytoplasmic incompatibility phenomenon and subsequent reduction in dengue incidences at target sites. Challenges for this strategy are to establish and maintain the transinfected mosquito population, choosing the appropriate strain of the bacteria, long term establishment of transinfected dengue mosquitoes for several subsequent generations, selecting the appropriate approach of mosquito field release, operational challenges, and the viral evolution. Moreover, the outcome of Wolbachia mediated biological control of Aedes aegypti in a broad scale is yet to be seen and the long-term stability of Wolbachia in transinfected mosquitoes remains unconfirmed. Significant success has been recorded in a broad scale deployment of wAlbB-carrying Aedes aegypti through the ongoing Wolbachia Malaysia project, resulting in a reduction in dengue fever cases. Successful large-deployment of this strategy has also been performed in Colombia and Indonesia (1.7 to 3.3 million people and 135–540 km² area). Similar investigations on broad scale for longer period across different environmental conditions using transinfected mosquito deployment and associated risk analysis are imperative before adopting this biological control approach as a potent dengue control strategy worldwide.